Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldini

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Expert Review of Hematology|November 1, 2016
Primary plasma cell leukemia 2.0: advances in biology and clinical managementAntonino Neri, Katia Todoerti, Marta Lionetti, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 6, 2010
Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parametersGiovanni Di Salvo, Giuseppe Pacileo, Giuseppe Limongelli, et al.
British Journal of Haematology|June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasiasStefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Human Pathology|February 28, 2003
Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulationGiancarlo Pruneri, Nadia Carboni, Luca Baldini, et al.
Cancer|February 28, 2009
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphomaStefano Luminari, Luigi Marcheselli, Stefano Sacchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?Paolo G Gobbi, Luca Baldini, Chiara Broglia, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2014
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma)Corrado Tarella, Luca Arcaini, Luca Baldini, et al.
Annals of Hematology|April 18, 2013
Bendamustine salvage therapy for T cell neoplasmsFrancesco Zaja, Luca Baldini, Andrés J M Ferreri, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Expert Review of Hematology|November 1, 2016
Primary plasma cell leukemia 2.0: advances in biology and clinical managementAntonino Neri, Katia Todoerti, Marta Lionetti, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 6, 2010
Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parametersGiovanni Di Salvo, Giuseppe Pacileo, Giuseppe Limongelli, et al.
British Journal of Haematology|June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasiasStefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Human Pathology|February 28, 2003
Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulationGiancarlo Pruneri, Nadia Carboni, Luca Baldini, et al.
Cancer|February 28, 2009
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphomaStefano Luminari, Luigi Marcheselli, Stefano Sacchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?Paolo G Gobbi, Luca Baldini, Chiara Broglia, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2014
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma)Corrado Tarella, Luca Arcaini, Luca Baldini, et al.
Annals of Hematology|April 18, 2013
Bendamustine salvage therapy for T cell neoplasmsFrancesco Zaja, Luca Baldini, Andrés J M Ferreri, et al.
Pageof 16